There is a maintenance window scheduled for MBS Online from 8:30pm to 10:00pm (AEST) on Thursday 30 July 2026. The search function may be unavailable during this maintenance window. We apologise for any inconvenience that may be caused.

Search the MBS

Standard Search

Advanced Search Search Tips

Enter keywords or item numbers below
Search Options

Results 1 to 1 of 1 matches

Category 6 - PATHOLOGY SERVICES

73329

73329 - Additional Information

Item Start Date:
01-Jul-2026
Description Updated:
01-Jul-2026
Schedule Fee Updated:
01-Jul-2026

Group
P7 - Genetics

A nucleic acid-based multi-gene panel test of tumour tissue from a patient with cholangiocarcinoma requested by, or on behalf of, a specialist or consultant physician, if the test is to:

(a)      detect at least IDH1 variant status, and

(b)      detect the fusion or rearrangement status of at least FGFR2; and

(c)      determine eligibility for a relevant treatment under the Pharmaceutical Benefits Scheme

including a service described in item 73319.

Applicable once per lifetime.



Fee: $800.00 Benefit: 75% = $600.00 85% = $695.50

Results 1 to 1 of 1 matches


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change